IN BRIEF: Poolbeg Pharma celebrates Australian patent “milestone”

03/31/26

IN BRIEF: Poolbeg Pharma celebrates Australian patent “milestone”

...

Poolbeg Pharma shares up after US FDA orphan drug designation

05/27/25

Poolbeg Pharma shares up after US FDA orphan drug designation

...

IN BRIEF: Poolbeg makes “significant breakthrough” in AI programme

11/08/22

IN BRIEF: Poolbeg makes “significant breakthrough” in AI programme

...

IN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccine

09/27/22

IN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccine

...

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis

06/27/22

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis

...

Poolbeg Pharma shares soar on US patent grants

05/26/22

Poolbeg Pharma shares soar on US patent grants

...

Poolbeg Pharma shares soar on US patent grants

05/26/22

Poolbeg Pharma shares soar on US patent grants

...

IN BRIEF: Poolbeg Pharma starts trading on OTCQB Venture Market

03/30/22

IN BRIEF: Poolbeg Pharma starts trading on OTCQB Venture Market

...

IN BRIEF: Poolbeg Pharma partners with Eurofins for RNA sequencing

10/07/21

IN BRIEF: Poolbeg Pharma partners with Eurofins for RNA sequencing

...

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.